Patents by Inventor Alex J. Buckmelter

Alex J. Buckmelter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS
    Publication number: 20240132499
    Abstract: The disclosure relates to USP30 Inhibitor Compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, and medical uses involving same.
    Type: Application
    Filed: September 27, 2023
    Publication date: April 25, 2024
    Inventors: Alex J. Buckmelter, Justin Andrew Caravella, Hongbin Li, Matthew W. Martin, Steven Mischke, David James Richard, Angela V. West
  • Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
    Patent number: 11814386
    Abstract: The disclosure relates to USP30 Inhibitor Compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, and medical uses involving same.
    Type: Grant
    Filed: October 20, 2022
    Date of Patent: November 14, 2023
    Assignee: FORMA Therapeutics, Inc.
    Inventors: Alex J. Buckmelter, Justin Andrew Caravella, Hongbin Li, Matthew W. Martin, Steven Mischke, David James Richard, Angela V. West
  • FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS
    Publication number: 20230126252
    Abstract: The disclosure relates to USP30 Inhibitor Compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, and medical uses involving same.
    Type: Application
    Filed: October 20, 2022
    Publication date: April 27, 2023
    Inventors: Alex J. Buckmelter, Justin Andrew Caravella, Hongbin Li, Matthew W. Martin, Steven Mischke, David James Richard, Angela V. West
  • Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
    Patent number: 11535618
    Abstract: The disclosure relates to USP30 Inhibitor Compounds I, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, and medical uses involving same.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: December 27, 2022
    Assignee: FORMA Therapeutics, Inc.
    Inventors: Alex J. Buckmelter, Justin Andrew Caravella, Hongbin Li, Matthew W. Martin, Steven Mischke, David James Richard, Angela V. West
  • FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS
    Publication number: 20210355126
    Abstract: The disclosure relates to USP30 Inhibitor Compounds I, pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, and medical uses involving same.
    Type: Application
    Filed: October 4, 2019
    Publication date: November 18, 2021
    Inventors: Alex J. Buckmelter, Justin Andrew Caravella, Hongbin Li, Matthew W. Martin, Steven Mischke, David James Richard, Angela V. West